Citation: P. Royburman et al., MOLECULAR HETEROGENEITY IN PROSTATE-CANCER - CAN TP53 MUTATION UNRAVEL TUMORIGENESIS, Molecular medicine today, 3(11), 1997, pp. 476-482
Citation: C. Boshoff et Ra. Weiss, ETIOLOGY OF KAPOSIS-SARCOMA - CURRENT UNDERSTANDING AND IMPLICATIONS FOR THERAPY, Molecular medicine today, 3(11), 1997, pp. 488-494
Citation: Ka. Williams et Dj. Coster, RETHINKING IMMUNOLOGICAL PRIVILEGE - IMPLICATIONS FOR CORNEAL AND LIMBAL STEM-CELL TRANSPLANTATION, Molecular medicine today, 3(11), 1997, pp. 495-501
Citation: Sc. Donnelly et R. Bucala, MACROPHAGE-MIGRATION INHIBITORY FACTOR - A REGULATOR OF GLUCOCORTICOID ACTIVITY WITH A CRITICAL ROLE IN INFLAMMATORY DISEASE, Molecular medicine today, 3(11), 1997, pp. 502-507
Citation: Gp. Bates et Sw. Davies, TRANSGENIC MOUSE MODELS OF NEURODEGENERATIVE DISEASE CAUSED BY CAG POLYGLUTAMINE EXPANSIONS/, Molecular medicine today, 3(11), 1997, pp. 508-515
Citation: S. Alberti, NOVEL DRUGS AND STRATEGIES FOR GASTROINTESTINAL DISORDERS - IBC-CONFERENCE ON GASTROINTESTINAL DISORDERS - CURRENT UNDERSTANDING, NEW APPROACHES TO PREVENTION AND TREATMENT - LONDON, UK, 23-24 JUNE 1997, Molecular medicine today, 3(10), 1997, pp. 416-417
Citation: Ah. Enk, ALLERGIC CONTACT-DERMATITIS - UNDERSTANDING THE IMMUNE-RESPONSE AND POTENTIAL FOR TARGETED THERAPY USING CYTOKINES, Molecular medicine today, 3(10), 1997, pp. 423-428
Citation: L. Mao, LEUKOPLAKIA - MOLECULAR UNDERSTANDING OF PREMALIGNANT LESIONS AND IMPLICATIONS FOR CLINICAL MANAGEMENT, Molecular medicine today, 3(10), 1997, pp. 442-448
Citation: J. Uitto et al., EPIDERMOLYSIS-BULLOSA - A SPECTRUM OF CLINICAL PHENOTYPES EXPLAINED BY MOLECULAR HETEROGENEITY, Molecular medicine today, 3(10), 1997, pp. 457-465
Citation: Dw. Knapp et Dj. Waters, NATURALLY-OCCURRING CANCER IN PET DOGS - IMPORTANT MODELS FOR DEVELOPING IMPROVED CANCER-THERAPY IN HUMANS, Molecular medicine today, 3(1), 1997, pp. 8-11
Citation: Pr. Colvillenash et Da. Willoughby, GROWTH-FACTORS IN ANGIOGENESIS - CURRENT INTEREST AND THERAPEUTIC POTENTIAL, Molecular medicine today, 3(1), 1997, pp. 14-23
Citation: Cm. Rooney et al., CONTROL OF VIRUS-INDUCED LYMPHOPROLIFERATION - EPSTEIN-BARR VIRUS-INDUCED LYMPHOPROLIFERATION AND HOST IMMUNITY, Molecular medicine today, 3(1), 1997, pp. 24-30